Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden

Pediatric Nephrology

Volumn 30, Issue 5, 2015, Pages 805-810

  Kusumi, Kirsten ^a   Becknell, Brian ^a   Schwaderer, Andrew ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Associated diagnoses; Health care burden; Healthcare Cost and Utilization Project (HCUP)

Indexed keywords

ADOLESCENT; CHILD; COMORBIDITY; ECONOMICS; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MALE; PEDIATRICS; TRENDS; UROLITHIASIS;

ADOLESCENT; CHILD; COMORBIDITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; PEDIATRICS; UROLITHIASIS;

EID: 84940007258     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-3012-3     Document Type: Article

References (38)

1. Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet 367:333–344
2. Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141–1152
3. Scales CD Jr, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA, Preminger GM (2007) Changing gender prevalence of stone disease. J Urol 177:979–982
4. Lotan Y (2009) Economics and cost of care of stone disease. Adv Chronic Kidney Dis 16:5–10
5. Sas DJ, Hulsey TC, Shatat IF, Orak JK (2010) Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr 157:132–137
6. Bush NC, Xu L, Brown BJ, Holzer MS, Gingrich A, Schuler B, Tong LY, Baker LA (2010) Hospitalizations for pediatric stone disease in United States, 2002–2007. J Urol 183:1151–1156
7. Routh JC, Graham DA, Nelson CP (2010) Epidemiological trends in pediatric urolithiasis at United States freestanding pediatric hospitals. J Urol 184:1100–1104
8. Matlaga BR, Schaeffer AJ, Novak TE, Trock BJ (2010) Epidemiologic insights into pediatric kidney stone disease. Urol Res 38:453–457
9. Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848–857
10. Gillen DL, Worcester EM, Coe FL (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67:685–690
11. Liu Y, Li S, Zeng Z, Wang J, Xie L, Li T, He Y, Qin X, Zhao J (2014) Kidney stones and cardiovascular risk: a meta-analysis of cohort studies. Am J Kidney Dis 64:402–410
12. Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4:804–811
13. Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21:1641–1644
14. Schaeffer AJ, Feng Z, Trock BJ, Mathews RI, Neu AM, Gearhart JP, Matlaga BR (2011) Medical comorbidities associated with pediatric kidney stone disease. Urology 77:195–199
15. Novak TE, Lakshmanan Y, Trock BJ, Gearhart JP, Matlaga BR (2009) Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation. Urology 74:104–107
16. Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21:257–264
17. Flegal KM, Tabak CJ, Ogden CL (2006) Overweight in children: definitions and interpretation. Health Educ Res 21:755–760
18. Kokorowski PJ, Routh JC, Hubert KC, Graham DA, Nelson CP (2012) Association of urolithiasis with systemic conditions among pediatric patients at children’s hospitals. J Urol 188:1618–1622
19. Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462
20. Heller HJ, Sakhaee K, Moe OW, Pak CY (2002) Etiological role of estrogen status in renal stone formation. J Urol 168:1923–1927
21. Bergsland KJ, Kinder JM, Asplin JR, Coe BJ, Coe FL (2002) Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol 167:2372–2376
22. Pietrow PK, Pope JCT, Adams MC, Shyr Y, Brock JW 3rd (2002) Clinical outcome of pediatric stone disease. J Urol 167:670–673
23. Borghi L, Nouvenne A, Meschi T (2012) Nephrolithiasis and urinary tract infections: ‘the chicken or the egg’ dilemma? Nephrol Dial Transplant 27:3982–3984
24. Welch BJ, Graybeal D, Moe OW, Maalouf NM, Sakhaee K (2006) Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis 48:555–563
25. Corbin Bush N, Twombley K, Ahn J, Oliveira C, Arnold S, Maalouf NM, Sakhaee K (2013) Prevalence and spot urine risk factors for renal stones in children taking topiramate. J Pediatr Urol 9:884–889
26. Israni RK, Kasbekar N, Haynes K, Berns JS (2006) Use of antiepileptic drugs in patients with kidney disease. Semin Dial 19:408–416
27. Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP (2007) Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol 22:375–378
28. Furth SL, Casey JC, Pyzik PL, Neu AM, Docimo SG, Vining EP, Freeman JM, Fivush BA (2000) Risk factors for urolithiasis in children on the ketogenic diet. Pediatr Nephrol 15:125–128
29. Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE (1982) Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 306:1136–1140
30. Craven BL, Passman C, Assimos DG (2008) Hypercalcemic states associated with nephrolithiasis. Rev Urol 10:218–226
31. Cury DB, Moss AC, Schor N (2013) Nephrolithiasis in patients with inflammatory bowel disease in the community. Int J Nephrol Renovasc Dis 6:139–142
32. Clark JH, Fitzgerald JF, Bergstein JM (1985) Nephrolithiasis in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 4:829–834
33. Lieske JC, de la Vega LS, Gettman MT, Slezak JM, Bergstralh EJ, Melton LJ 3rd, Leibson CL (2006) Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis 48:897–904
34. Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230–1235
35. Faggiano A, Pivonello R, Melis D, Filippella M, Di Somma C, Petretta M, Lombardi G, Colao A (2003) Nephrolithiasis in Cushing’s disease: prevalence, etiopathogenesis, and modification after disease cure. J Clin Endocrinol Metab 88:2076–2080
36. Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11:7227–7236
37. Soucie JM, Coates RJ, McClellan W, Austin H, Thun M (1996) Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143:487–495
38. Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci U S A 105:9841–9846